Wall Street Zen upgraded shares of Sotera Health (NASDAQ:SHC – Free Report) from a buy rating to a strong-buy rating in a research note published on Sunday morning,Wall Street Zen reports.
Several other brokerages also recently commented on SHC. Weiss Ratings downgraded shares of Sotera Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday. Citigroup upped their target price on shares of Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a report on Friday, August 7th. Piper Sandler reiterated an “overweight” rating and issued a $25.00 price target on shares of Sotera Health in a research note on Tuesday, September 8th. JPMorgan Chase & Co. reissued an “underweight” rating and set a $17.00 price target on shares of Sotera Health in a report on Wednesday, October 14th. Finally, Barclays raised their price target on Sotera Health from $19.00 to $22.00 and gave the company an “overweight” rating in a report on Friday, August 7th. Eight investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Sotera Health presently has an average rating of “Moderate Buy” and a consensus price target of $21.38.
View Our Latest Stock Report on Sotera Health
Sotera Health Stock Performance
Sotera Health stock opened at $18.10 on Friday. The firm has a 50 day moving average of $18.56 and a 200 day moving average of $17.30. The firm has a market capitalization of $5.17 billion, a price-to-earnings ratio of 31.75 and a beta of 1.85. Sotera Health has a 12-month low of $13.09 and a 12-month high of $19.85. The company has a current ratio of 2.80, a quick ratio of 2.55 and a debt-to-equity ratio of 3.33.
Sotera Health (NASDAQ:SHC – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.26 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.02. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. The company had revenue of $321.38 million for the quarter, compared to analysts’ expectations of $309.70 million. During the same quarter last year, the business earned $0.20 EPS. The firm’s revenue was up 9.2% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. As a group, research analysts predict that Sotera Health will post 0.87 earnings per share for the current year.
Insider Buying and Selling
In other news, Chairman Michael Petras, Jr. sold 850,000 shares of the business’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $18.50, for a total value of $15,725,000.00. Following the transaction, the chairman owned 3,969,393 shares of the company’s stock, valued at approximately $73,433,770.50. The trade was a 17.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Michael Rutz sold 150,000 shares of the firm’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the transaction, the insider directly owned 334,279 shares of the company’s stock, valued at $6,297,816.36. The trade was a 30.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 1,294,515 shares of company stock valued at $23,999,528. Insiders own 15.36% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the company. Militia Capital Management LLC purchased a new stake in shares of Sotera Health in the first quarter worth about $3,877,000. Public Employees Retirement System of Ohio purchased a new position in shares of Sotera Health in the second quarter valued at $1,440,000. Bank of New York Mellon Corp grew its holdings in shares of Sotera Health by 13.4% in the first quarter. Bank of New York Mellon Corp now owns 1,403,971 shares of the company’s stock valued at $20,133,000 after purchasing an additional 166,055 shares in the last quarter. Balefire LLC bought a new stake in Sotera Health in the first quarter worth $1,476,000. Finally, BlackRock Inc. bought a new stake in Sotera Health in the second quarter worth $428,635,000. Hedge funds and other institutional investors own 91.03% of the company’s stock.
About Sotera Health
Sotera Health Company (NASDAQ: SHC) is a healthcare services company focused on sterilization, laboratory testing and infection prevention. Its services support manufacturers and providers across the medical device, pharmaceutical, tissue, food safety and other healthcare-related industries.
The company operates through three primary businesses. Sterigenics provides outsourced sterilization services, including ethylene oxide, gamma irradiation and electron-beam processing. Nelson Labs offers laboratory testing, analytical services and consulting for medical devices, pharmaceuticals and other healthcare products.
Further Reading
- Five stocks we like better than Sotera Health
- Newmont’s Record Quarter Shows Why Gold’s Floor Is the Real Story
- Albemarle Upgrade: Can Energy Storage Recharge Lithium’s Leader?
- Consumer Staples Are Up 12% This Year—These 3 Beverage Stocks Are Leading the Way
- Can Planet Fitness Get Its Growth Back in Shape?
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.
